Interpace Biosciences Correlations
| IDXGDelisted Stock | USD 2.20 0.00 0.00% |
The current 90-days correlation between Interpace Biosciences and Intelligent Bio Solutions is -0.26 (i.e., Very good diversification). The correlation of Interpace Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Interpace Biosciences Correlation With Market
Good diversification
The correlation between Interpace Biosciences and DJI is -0.06 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Interpace Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Interpace |
The ability to find closely correlated positions to Interpace Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Interpace Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Interpace Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Interpace Biosciences to buy it.
Moving against Interpace OTC Stock
| 0.63 | AWH | Aspira Womens Health | PairCorr |
| 0.56 | MMA | Alta Global Group | PairCorr |
| 0.56 | PRE | Prenetics Global | PairCorr |
| 0.53 | LAB | Standard Biotools | PairCorr |
| 0.44 | OCX | OncoCyte Corp | PairCorr |
| 0.36 | FLGT | Fulgent Genetics | PairCorr |
| 0.5 | GENE | Genetic Technologies | PairCorr |
| 0.48 | NDRA | ENDRA Life Sciences | PairCorr |
| 0.44 | PSNL | Personalis | PairCorr |
| 0.42 | XWEL | XWELL Inc | PairCorr |
| 0.42 | MDXH | MDxHealth SA ADR | PairCorr |
| 0.41 | MYNZ | Mainz Biomed BV | PairCorr |
| 0.35 | MEDP | Medpace Holdings | PairCorr |
| 0.32 | APDN | Applied DNA Sciences Earnings Call This Week | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Interpace OTC Stock performing well and Interpace Biosciences OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Interpace Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| INBS | 5.73 | 0.70 | 0.09 | 4.67 | 6.10 | 13.16 | 40.29 | |||
| BIAF | 4.26 | (0.34) | 0.00 | (0.28) | 0.00 | 10.10 | 61.86 | |||
| SQL | 4.56 | 0.16 | 0.00 | (0.18) | 4.49 | 12.50 | 50.87 | |||
| BIOC | 6.16 | (2.63) | 0.00 | (2.25) | 0.00 | 9.24 | 66.54 | |||
| FONR | 1.49 | (0.15) | 0.00 | (0.10) | 0.00 | 2.15 | 10.60 | |||
| BNR | 5.38 | (0.03) | 0.01 | 0.10 | 7.90 | 15.95 | 46.14 | |||
| SERA | 3.84 | (0.36) | 0.00 | (0.01) | 0.00 | 9.55 | 27.67 | |||
| OLK | 0.63 | 0.13 | 0.07 | 0.50 | 0.48 | 1.58 | 4.37 | |||
| LMDX | 4.74 | (0.96) | 0.00 | (0.64) | 0.00 | 11.54 | 34.05 | |||
| HTGM | 9.08 | (1.49) | 0.00 | 1.63 | 0.00 | 25.00 | 65.45 |
View Interpace Biosciences Related Equities
| Risk & Return | Correlation |
Interpace Biosciences Corporate Management
Elected by the shareholders, the Interpace Biosciences' board of directors comprises two types of representatives: Interpace Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Interpace. The board's role is to monitor Interpace Biosciences' management team and ensure that shareholders' interests are well served. Interpace Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Interpace Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Burnell | CEO Pres | Profile | |
| Sydney Finkelstein | Chief Officer | Profile | |
| Patrick Kane | VP Controller | Profile | |
| Jody Campbell | Chief Officer | Profile | |
| Thomas Freeburg | Chief Accounting Officer and Principal Accounting Officer | Profile | |
| Susanne Reilly | Chief Officer | Profile |
Still Interested in Interpace Biosciences?
Investing in delisted otcs can be risky, as the otc stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.